Ph.D., Founder & CEO, Carcinomix
Hendrik van Geel founded Carcinomix to provide comprehensive diagnostic and data-driven treatment decision support through a single platform for genetic analysis. His background in theoretical physics helped him to develop a mathematical model and an algorithm that accounts for the underlying biological and chemical mechanisms. He is passionate about building a multi-disciplinary team to advance precision medicine. Prior to Carcinomix, Hendrik sold and delivered large scale global IT solutions. He started his career as a consultant with companies such as IBM and Deloitte Consulting advising Fortune 500 companies. He holds a Ph. D. in Theoretical Physics from Goethe University, Frankfurt, Germany.
AI & Data Sciences Showcase: Carcinomix
A platform for genetic analysis based on a mathematical model and an algorithm that accounts for the underlying biological and chemical mechanisms.
Symmetry Considerations In Mathematical Biology And Genetics
Using the symmetric properties of the genetic code allows us to create applications for therapy-matching and gene-editing in precision medicine. Based on a solid algorithm these applications are based on root-causes instead of correlation and offer a validation of the approach.